Trial Profile
Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Nov 2010
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary) ; Mycophenolate mofetil (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 15 Nov 2010 New trial record
- 16 Oct 2010 Results were presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.